IGF1R and breast cancer: On the other hand, MCF-7 breast cancer cells with acquired resistance to IGF-1R tyrosine kinase inhibition exhibit reduced basal OCR (Lyons et al., 2017), and silencing of IGF-1R in human colon cancer cells increases the maximal OCR (S. Q. Wang et al., 2019b).